Ying-Kai Wang
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 10
- Antifungal resistance and susceptibility 3
- Hepatology 12
- Hepatitis C virus research 12
- Co-authors
- Elena Rustchenko (2 shared papers)Rachel A. Baker (1 shared paper)Richard D. Cannon (1 shared paper)Frank Fischer (1 shared paper)Fred Sherman (1 shared paper)Masakazu Niimi (1 shared paper)Karen Rigat (8 shared papers)Susan B. Roberts (10 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Bacteriology (2 papers)Oncology Reports (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Archives of Biochemistry and Biophysics (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Ying-Kai Wang
22 papers receiving 418 citations
Peers
Comparison fields: 5 of 62
- Hepatology 111
- Infectious Diseases 226
- Epidemiology 186
- Business and International Management 8
- Organic Chemistry 71
Countries citing papers authored by Ying-Kai Wang
This map shows the geographic impact of Ying-Kai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying-Kai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying-Kai Wang more than expected).
Fields of papers citing papers by Ying-Kai Wang
This network shows the impact of papers produced by Ying-Kai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying-Kai Wang. The network helps show where Ying-Kai Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying-Kai Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 119 | |
| 2 | 2014 | 47 | |
| 3 | 2005 | 43 | |
| 4 | 2006 | 28 | |
| 5 | 2011 | 22 | |
| 6 | 2014 | 20 | |
| 7 | 2014 | 17 | |
| 8 | 2006 | 16 | |
| 9 | 2021 | 16 | |
| 10 | 2012 | 15 | |
| 11 | 2024 | 13 | |
| 12 | 2011 | 11 | |
| 13 | 1998 | 9 | |
| 14 | 2017 | 8 | |
| 15 | 2011 | 8 | |
| 16 | 2017 | 8 | |
| 17 | 2007 | 7 | |
| 18 | 2011 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 3 |
About Ying-Kai Wang
Ying-Kai Wang is a scholar working on Infectious Diseases, Hepatology, Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 22 papers that have together received 426 indexed citations. Recurring topics across this work include Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (10 papers), Hepatitis B Virus Studies (7 papers), Antifungal resistance and susceptibility (3 papers), MicroRNA in disease regulation (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Fungal Infections and Studies (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Hepatology (111 citations), Infectious Diseases (226 citations), Epidemiology (186 citations), Business and International Management (8 citations) and Organic Chemistry (71 citations). Ying-Kai Wang has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Elena Rustchenko, Rachel A. Baker, Richard D. Cannon, Frank Fischer, Fred Sherman, Masakazu Niimi, Karen Rigat, Susan B. Roberts, Jay Greenberg and M. Anaul Kabir. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Bacteriology, Oncology Reports, Antimicrobial Agents and Chemotherapy and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.